Latest Psychosis Stories
Tetra Discovery Partners Focused on PDE4D Inhibitors as Novel Approach to Treating Cognitive Impairment in Schizophrenia, Alzheimer's Disease, and Huntington's Disease GRAND RAPIDS,
MONTREAL, April 3, 2014 /CNW Telbec/ - Bruno Giros, PhD, a researcher at the Douglas Mental Health University Institute and a professor in the Department of Psychiatry at McGill University,
People with schizophrenia often misinterpret what they see and experience in the world.
-- Conference Focuses on New Drug Development and Cutting Edge Research in Schizophrenia -- SEATTLE, April 1, 2014 /PRNewswire/ -- Omeros Corporation (NASDAQ: OMER) today announced
NEW YORK, March 10, 2014 /PRNewswire/ -- Intra-Cellular Therapies, Inc.
ADASUVE is the first and only orally inhaled medicine for the acute treatment of agitation associated with schizophrenia or bipolar I disorder in adults MOUNTAIN VIEW, Calif., March 3, 2014
NEW YORK, Feb. 26, 2014 /PRNewswire/ -- Intra-Cellular Therapies, Inc. (NASDAQ: ITCI) today announced Dr.
Where a person lives should not determine the treatment he or she is able to receive, says the Treatment Advocacy Center. Arlington, Virginia (PRWEB) February
-- PDE10 Target Engagement Continues to Increase with Well-Tolerated Doses -- SEATTLE, Feb.
- The horn of a unicorn considered as a medical or pharmacological ingredient.
- A winged horse with a single horn on its head; a winged unicorn.